MicroRNA-218-5p as a Potential Target for the Treatment of Human Osteoarthritis

Jun Lu1, Ming-Liang Ji1, Xue-Jun Zhang1

  • 1Department of Orthopaedic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.

Insights

MicroRNA-218-5p (miR-218-5p) is elevated in osteoarthritis and drives cartilage destruction by impacting PI3K/Akt/mTOR signaling. Inhibiting miR-218-5p shows promise for treating osteoarthritis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Orthopedics

Background:

  • Dysregulated microRNAs (miRNAs) are implicated in osteoarthritis (OA) pathogenesis.
  • The specific roles of individual miRNAs in OA progression require further elucidation.

Purpose of the Study:

  • To identify and functionally validate specific miRNAs associated with OA.
  • To investigate the role of miR-218-5p in OA development and explore its therapeutic potential.

Main Methods:

  • miRNA expression profiling in OA tissues.
  • Gain-of-function and loss-of-function studies in chondrocyte cell lines (SW1353, C28/I2).
  • In vivo studies using an OA mouse model with miR-218-5p inhibition.

Main Results:

  • miR-218-5p is significantly upregulated in moderate to severe OA and correlates with Mankin scores.
  • miR-218-5p modulates chondrocyte proliferation, apoptosis, and matrix synthesis gene expression.
  • PIK3C2A was identified as a direct target of miR-218-5p, impacting the PI3K/Akt/mTOR pathway.
  • Inhibition of miR-218-5p in OA mice protected against cartilage degradation and proteoglycan loss.

Conclusions:

  • miR-218-5p is a novel inducer of cartilage destruction in OA through PI3K/Akt/mTOR signaling.
  • Inhibiting miR-218-5p represents a potential therapeutic strategy for osteoarthritis treatment.